Christopher Ogden

Business address
C/O Cytomx Therapeutics, Inc., 151 Oyster Point Blvd., Suite 400, South San Francisco, CA, 94080
Top holdings (ownership)
CTMX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Christopher Ogden has filed 14 SEC EDGAR filings since 09 Mar 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 30 Sep 2025 26 Sep 2025 001-37587
4 Open Document Open Filing 17 Jun 2025 13 Jun 2025 001-37587
4 Open Document Open Filing 20 Mar 2025 18 Mar 2025 001-37587
4 Open Document Open Filing 06 Feb 2025 04 Feb 2025 001-37587
4 Open Document Open Filing 22 Aug 2024 20 Aug 2024 001-37587
4 Open Document Open Filing 14 Jun 2024 12 Jun 2024 001-37587
4 Open Document Open Filing 21 Mar 2024 19 Mar 2024 001-37587
4 Open Document Open Filing 19 Jan 2024 18 Jan 2024 001-37587
4 Open Document Open Filing 22 Dec 2023 20 Dec 2023 001-37587
4 Open Document Open Filing 19 Dec 2023 17 Dec 2023 001-37587
4 Open Document Open Filing 20 Mar 2023 16 Mar 2023 001-37587
4 Open Document Open Filing FORM 4 06 Feb 2023 02 Feb 2023 001-37587
4 Open Document Open Filing FORM 4 12 Aug 2022 10 Aug 2022 001-37587
3 Open Document Open Filing FORM 3 09 Mar 2022 14 Feb 2022 001-37587